Abbott Cephea Mitral Valve Disease Registry

Summary

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Mitral Regurgitation
• Mitral Stenosis
• Mitral Valve Disease
• Mitral Valve (MV) Regurgitation
• Mitral Annulus Calcification
• Mitral Valve Replacement
• Transcatheter Valve Replacement

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

18 years and older

Sex

All

Healthy volunteers

Not accepted

Sponsor

Abbott Medical Devices

Last updated on ClinicalTrials.gov

September 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites